| Product Information |
| Synonym(s) |
1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo[f]quinoxaline-7-sulfonamide; FG9202; NBQX |
| Chemical Name |
6-nitro-2,3-dioxo-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide |
| Application |
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity. |
| CAS Number |
118876-58-7 |
| Purity |
¡Ý98.0% |
| Molecular Weight |
336.28 |
| Molecular Formula |
C12H8N4O6S |
| SMILES |
O=S(N)(C1=CC=CC(C1=C2[N+]([O-])=O)=C(C(NC3=O)=C2)NC3=O)=O |
| Target & IC50 |
HEK293: IC50 = 50uM |
| Solubility |
DMSO: ¡Ý 75 mg/mL (223.03 mM) |
| Preparing Stock Solutions |
| ConcentrationSolventMass |
1 mg |
5 mg |
10 mg |
| 1 mM |
2.9737 ml |
14.8686 ml |
29.7371 ml |
| 5 mM |
0.5947 ml |
2.9737 ml |
5.9474 ml |
| 10 mM |
0.2974 ml |
1.4869 ml |
2.9737 ml |
| 50 mM |
0.0595 ml |
0.2974 ml |
0.5947 ml |
|
| Shipping |
Gel Pack |
| Storage |
Store at -20¡ãC |
| Research Use |
For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |